EUVIMEDEUVIMED entdecken
Crossref

Weight loss and body composition after compounded semaglutide treatment in a real world setting

Elizabeth Chun, Alexandra Siojo, David Rivera, Kirsten Reyna, Henry Legere, Richard Joseph, Rachele Pojednic iD

Diabetes, Obesity and Metabolism · 2025-03 · 27 (3) · 1536-1543

DOI: 10.1111/dom.16162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 07.01.2025. Verfasst von Elizabeth Chun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, Texas A&M University, College Station, Texas, USA. Hauptthemen laut MEDLINE: Body Composition, Weight Loss, Glucagon-Like Peptides, Obesity. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Clinical trials have shown efficacy of semaglutide for weight loss, but further study is needed in less controlled environments including impacts on body composition. Materials and Methods This retrospective study included individuals who participated in a weight management programme at a commercial wellness studio receiving once‐weekly compounded semaglutide/cyanocobalamin injections from June 2023 to January 2024. Once‐weekly semaglutide/cyanocobalamin injected subcutaneously starting at 0.25 mg/0.125 mg and titrated to a maximum dose of 2.4 mg/0.24 mg. The primary endpoint was weight loss at 3 months, with secondary analyses including weight loss percentage, weight loss by body mass index (BMI) class and body composition changes including changes in total fat mass, lean body mass, skeletal muscle mass and trunk adiposity.

Results

A total of 94 individuals were analysed (81F/13M), age in years mean (SD) = 46.57 (10.60). After 3 months, average weight loss was 4.11 (2.77) kg or 4.57% (2.96%). Individuals lost fat mass (2.67 (2.37) kg) and trunk fat mass (1.10 (1.36) kg), while also losing small amounts of lean mass (1.43 (1.41) kg) and skeletal muscle mass (0.88 (0.81) kg). As a proportion of total weight, fat mass decreased while lean muscle mass and skeletal muscle mass increased.

Discussion

This study demonstrates that meaningful weight loss is achievable on semaglutide/cyanocobalamin outside of a closely controlled environment. In addition, body composition improved with losses in fat mass and gains in overall proportion of lean muscle and skeletal muscle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Body CompositionWeight LossGlucagon-Like PeptidesObesityAnti-Obesity AgentsHumansMaleFemaleMiddle AgedRetrospective StudiesAdultBody Mass IndexTreatment OutcomeGlucagon-Like Peptide 1Semaglutide

Stichwörter der Autor:innen

GLP‐1antiobesity drugbody compositioncohort studyreal‐world evidencesemaglutide

Substanzen

Glucagon-Like PeptidesAnti-Obesity AgentsGlucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • Department of Statistics, Texas A&M University, College Station, Texas, USA.
  • Restore Hyper Wellness, Austin, Texas, USA.
  • University of Connecticut, Storrs, Connecticut, USA.
  • Division of Preventive Medicine, Mass General Brigham, Boston, Massachusetts, USA.
  • Stanford Lifestyle Medicine, Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, California, USA.

ORCID-Profile: Rachele Pojednic

Zitieren

APA

Chun, E., Siojo, A., Rivera, D., Reyna, K., Legere, H., Joseph, R., & Pojednic, R. (2025). Weight loss and body composition after compounded semaglutide treatment in a real world setting. Diabetes, Obesity and Metabolism, 27(3), 1536-1543. https://doi.org/10.1111/dom.16162

Vancouver

Chun E, Siojo A, Rivera D, Reyna K, Legere H, Joseph R, et al. Weight loss and body composition after compounded semaglutide treatment in a real world setting. Diabetes, Obesity and Metabolism. 2025;27(3):1536-1543. doi:10.1111/dom.16162

BibTeX
@article{Chun2025,
  author = {Chun, Elizabeth and Siojo, Alexandra and Rivera, David and Reyna, Kirsten and Legere, Henry and Joseph, Richard and Pojednic, Rachele},
  title = {Weight loss and body composition after compounded semaglutide treatment in a real world setting},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  volume = {27},
  number = {3},
  pages = {1536--1543},
  doi = {10.1111/dom.16162}
}
Kostenlos starten →